000 | 00974 a2200289 4500 | ||
---|---|---|---|
005 | 20250513095302.0 | ||
264 | 0 | _c19960918 | |
008 | 199609s 0 0 eng d | ||
022 | _a1262-3636 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSavage, M O | |
245 | 0 | 0 |
_aRecombinant IGF-I therapy in insulin-dependent diabetes mellitus. _h[electronic resource] |
260 |
_bDiabetes & metabolism _cJul 1996 |
||
300 |
_a257-60 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aControlled Clinical Trials as Topic |
650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _xdrug therapy |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 |
_aGrowth Hormone _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInsulin-Like Growth Factor I _xmetabolism |
650 | 0 | 4 |
_aRecombinant Proteins _xmetabolism |
650 | 0 | 4 | _aReference Values |
700 | 1 | _aDunger, D B | |
773 | 0 |
_tDiabetes & metabolism _gvol. 22 _gno. 4 _gp. 257-60 |
|
999 |
_c8763992 _d8763992 |